{
    "paper_id": "5ea24d202f1df5e0c418f920a63fa270c07d46bd",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Aspiration (Continued) radiography of, 611-612, 611f-614f upper airway obstruction due to, 406-407 functional developmental anatomy and, 592-596 historical background of, 592 hydrocarbon, 653-655, 654f iatrogenic, 595, 595f, 596f interstitial lung disease due to, 666 of lipid-containing liquids, 603f, 604 micro-(silent), 596-597, 598 of mucus, 595 risk factors for, 478 Breathing pattern (s) and aerosol therapy, 270-271 inspection of, 77-78 respiratory muscle weakness and, 197 Bronchial abnormalities, [295] [296] [297] [298] 296f, 297f, 297t Bronchial adenoma, 711, 712f Bronchial arteries, 32 Bronchial atresia, [295] [296] 302, 302f Bronchial biopsy, 390 Bronchial branching, abnormal, 296 Bronchial brushing, due to asphyxiating thoracic dystrophy, 744-745 due to botulism, 741-742 causes of, 735-736, 736f, 736t due to cerebral palsy, 736 chronic respiratory failure due to, 251 due to diaphragmatic paralysis, 736-737, 737b due to familial dysautonomia, 979, 980f due to Friedreich's ataxia, 736 general considerations for, 733-736 due to Guillain-Barr\u00e9 syndrome, 737 laboratory assessment of respiratory function with, 733-734 management of, 734-735 due to motor neuron diseases, 736-738, 736b, 738b due to muscle diseases, 736b, 737-740 due to muscular dystrophies, 737-740 due to myasthenia gravis, 740-741 due to neuromuscular junction diseases, 736b, 740-742 due to obesity, 745 due to obstructive pulmonary disease, 745 due to poliomyelitis, 736 respiratory failure with clinical signs and symptoms of, 733, 735b pathogenesis of, 733, 734f respiratory muscle fatigue due to, 733, 734f, 735b due to scoliosis, 742-744, 742b due to skeletal anomalies, 736b, 742-745, 742b due to spinal cord injury, 736 due to spinal muscular atrophies, 736 Chest wall function guidelines for assessment of, 735b in infants and preschool children, 190-192, 191f , 192f biologic relevance of, 186, 187f carbon dioxide output during, [188] [189] [190] 189f, 190f cardiorespiratory response to, [188] [189] [190] [191] [192] [193] 189f gas exchange response to, [193] [194] [195] 193t, 194f and growth, 186, 187f heart rate response to, [192] [193] 192f, 195, 196, [191] [192] 191f, 192f maximal voluntary ventilation during, 195 oxygen cost of, 193t oxygen uptake during, [190] [191] [192] 191f, 192f, 193, 196, 196f response time of gas exchange adaptations to, 193t ventilatory responses to, [188] [189] [190] 189f, 190f, 193t VO 2 during, 58 Exercise testing, [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [195] [196] 196f for asthma, 200, 817 biologic approach toward, [186] [187] [188] 200, 201 methods for, 197 normal values for, 198 obesity and, 196 progressive protocols for, [195] [196] 196f safety of, [197] [198] 743 size and, [196] [197] [193] [194] [195] 193t, [198] [199] [200] [201] 199f, [815] [816] , 193-195, 193t, 194f Gas exchange analysis systems, in exercise testing, 197 Gas flow, within airways, 41-42 Gas laws, 37-38 Gas resorption, atelectasis due to, 616-617 Gas stoves, and chronic/recurrent bronchitis, 420, 421t Gas transport, 51-59 of carbon dioxide, and acid-base balance, 55-58, 56f, 57t of oxygen, 51-53, 52f, 53t in oxygen therapy, 53-55, 54b and tissue respiration, 58-59 Gas washout technique, 139-140, 139f, 140f Gas-exchanging vessels, 44 Gas-mixing efficiency, 140-142, 142f, 143f Gastric scintiscan, for gastroesophageal reflux, 600-601, 601t, 602 Gastroenteric cysts, 298, 718-720 Gastroesophageal reflux (GER) and acute life-threatening events, 1029-1030, 1029f and apnea, 599, 1029-1030, 1029f and asthma, 816 bronchial wall thickening due to, 118f defined, 592 diagnosis of, 600-603, 600b, 601t, 602f, 602t disorders associated with, 599, 599b in familial dysautonomia, 978 historical background of, 592 lower esophageal sphincter pressure in, 597-598, 598t medical management of, 604-605, 604b in newborn, 319-320 physiologic vs. pathologic, 601, 602t protection against, 597-598 pulmonary impact of, 593, 596-597 surgical management of, 605-606 symptoms of, 598-600, 599b Gastroesophageal reflux disease (GERD) and , 192-193, 192f, 195, 196, 196f House dust mite (HDM), and asthma (Continued) properties of, 788t, 789t scanning electron microscopy of, 789f Hox (homeotic/homeodomain) genes, in lung morphogenesis, 1, 7 HP. See Hypersensitivity pneumonitis (HP). HR (heart rate) exercise and, 192-193, 192f, 195, 196, 196f in acute lung injury, 230 in airway inflammation, 69, 70 Interleukin-2 (IL-2), lung injury due to, 1001t, 1007 Interleukin-3 (IL-3), in eosinophil maturation, 218 Interleukin-4 (IL-4), in airway inflammation, 69 in airway inflammation, 67, 69 in eosinophil maturation, 218 Interleukin-6 (IL-6) in acute lung injury, 230 in airway inflammation, 69 in exercise- induced asthma, 199, in acute lung injury, 230 in cystic fibrosis, 875-876 Interleukin-9 (IL-9), in airway inflammation, 69 Interleukin-10 (IL-10), in airway inflammation, 72 Interleukin-12 (IL-12), in airway inflammation, 72 in lung injury and repair, 9, 11 branching, 2, 9, 9f control of lung proliferation in, 10.10b in canalicular period, 2-4, 2t, 4f-6f, 34, 35, 35f cell adhesion molecules in, 11 cell shape in, 11 control of gene transcription in, 6-8, 6f, 7f chromatin structure in, 7f, 8 combinational, 7f, 8 gradients of signaling molecules and localization of receptor molecules in, 7f, 8 receptor-mediated signal transduction in, 7f, 8 transcriptional cascades/hierarchies in, 7, 7f in embryonic period, 2, 2t, 3f, 5f-6f, 34, 35, 35f epithelial-mesenchymal interactions and, 2, 9, 9f extracellular matrix in, 10-11 gene mutations in, 12 gradients of signaling molecules and localization of receptor molecules in, 7f, 8 host defense systems in, 11-12 in mouse, 2, 5f-6f nontranscriptional mechanisms in, 8 overview of, 1-2, 2t, 3f-4f in pseudoglandular period, 2, 2t, 3f, 5f-6f, 34, 35, 35f in saccular period, 2t, 4, 4f-6f, 9, 24, 34- [190] [191] [192] 191f, 192f, 193, 196, 196f maximal, 193t, 194, 194f Oxygenation, excessive, Tuberculosis (TB) (Continued) collapse-consolidation lesion in, 512, 512f, 513f control and prevention of, 521-522 disseminated, 511 drug susceptibility testing for, 507 epidemiology of, 508-510, 509f, 510f evolution of clinical disease in, 510-516, 511f-516f extrathoracic, 515-516, 516f, 521 Ghon focus in, 511 high-resolution computed tomography of, 124f hilar adenopathy in, 512, 512f HIV and, 515, 582 in immunocompromised host, 459 immunology of, 508 intrathoracic, 511-515, 512f-515f laboratory diagnosis of, 518-519, 518t latent, 510, 517, 519, 520t lymphadenopathy in, 512-513 lymphohematogenous spread of, 514-515 miliary, 515, 515f multidrug-resistant, 520t, 521 mycobacteriology of, 507-508 osteo-, 521 pathophysiology of, 510 pleural, 514, 514f pneumonia due to, 443 protracted hematogenous, 514 radiographic appearance of, 510-516, 511f-516f risk factors for, 508-509 of superficial lymph nodes, 515 therapy for, 519-521, 520t of thymus gland, 721 transmission of, 508-509 tuberculin skin test for, 516-518, 517b ultrasonography of, 127f window prophylaxis for, 519 [190] [191] [192] 191f, 192f, 193, 196, 196f maximal, 193t, 194, 194f VO 2 /HR slope, 193t VO 2max (maximal oxygen uptake), 193t, 194, ",
            "cite_spans": [
                {
                    "start": 11,
                    "end": 22,
                    "text": "(Continued)",
                    "ref_id": null
                },
                {
                    "start": 368,
                    "end": 371,
                    "text": "478",
                    "ref_id": null
                },
                {
                    "start": 390,
                    "end": 393,
                    "text": "(s)",
                    "ref_id": null
                },
                {
                    "start": 463,
                    "end": 476,
                    "text": "weakness and,",
                    "ref_id": null
                },
                {
                    "start": 477,
                    "end": 505,
                    "text": "197 Bronchial abnormalities,",
                    "ref_id": null
                },
                {
                    "start": 506,
                    "end": 511,
                    "text": "[295]",
                    "ref_id": null
                },
                {
                    "start": 512,
                    "end": 517,
                    "text": "[296]",
                    "ref_id": null
                },
                {
                    "start": 518,
                    "end": 523,
                    "text": "[297]",
                    "ref_id": null
                },
                {
                    "start": 524,
                    "end": 529,
                    "text": "[298]",
                    "ref_id": null
                },
                {
                    "start": 530,
                    "end": 535,
                    "text": "296f,",
                    "ref_id": null
                },
                {
                    "start": 536,
                    "end": 541,
                    "text": "297f,",
                    "ref_id": null
                },
                {
                    "start": 542,
                    "end": 565,
                    "text": "297t Bronchial adenoma,",
                    "ref_id": null
                },
                {
                    "start": 566,
                    "end": 570,
                    "text": "711,",
                    "ref_id": null
                },
                {
                    "start": 571,
                    "end": 595,
                    "text": "712f Bronchial arteries,",
                    "ref_id": null
                },
                {
                    "start": 596,
                    "end": 617,
                    "text": "32 Bronchial atresia,",
                    "ref_id": null
                },
                {
                    "start": 618,
                    "end": 623,
                    "text": "[295]",
                    "ref_id": null
                },
                {
                    "start": 624,
                    "end": 629,
                    "text": "[296]",
                    "ref_id": null
                },
                {
                    "start": 630,
                    "end": 634,
                    "text": "302,",
                    "ref_id": null
                },
                {
                    "start": 635,
                    "end": 657,
                    "text": "302f Bronchial biopsy,",
                    "ref_id": null
                },
                {
                    "start": 658,
                    "end": 682,
                    "text": "390 Bronchial branching,",
                    "ref_id": null
                },
                {
                    "start": 683,
                    "end": 692,
                    "text": "abnormal,",
                    "ref_id": null
                },
                {
                    "start": 693,
                    "end": 716,
                    "text": "296 Bronchial brushing,",
                    "ref_id": null
                },
                {
                    "start": 1845,
                    "end": 1858,
                    "text": "190-192, 191f",
                    "ref_id": null
                },
                {
                    "start": 1929,
                    "end": 1934,
                    "text": "[188]",
                    "ref_id": null
                },
                {
                    "start": 1935,
                    "end": 1940,
                    "text": "[189]",
                    "ref_id": null
                },
                {
                    "start": 1941,
                    "end": 1946,
                    "text": "[190]",
                    "ref_id": null
                },
                {
                    "start": 1947,
                    "end": 1952,
                    "text": "189f,",
                    "ref_id": null
                },
                {
                    "start": 1953,
                    "end": 1988,
                    "text": "190f cardiorespiratory response to,",
                    "ref_id": null
                },
                {
                    "start": 1989,
                    "end": 1994,
                    "text": "[188]",
                    "ref_id": null
                },
                {
                    "start": 1995,
                    "end": 2000,
                    "text": "[189]",
                    "ref_id": null
                },
                {
                    "start": 2001,
                    "end": 2006,
                    "text": "[190]",
                    "ref_id": null
                },
                {
                    "start": 2007,
                    "end": 2012,
                    "text": "[191]",
                    "ref_id": null
                },
                {
                    "start": 2013,
                    "end": 2018,
                    "text": "[192]",
                    "ref_id": null
                },
                {
                    "start": 2019,
                    "end": 2024,
                    "text": "[193]",
                    "ref_id": null
                },
                {
                    "start": 2025,
                    "end": 2055,
                    "text": "189f gas exchange response to,",
                    "ref_id": null
                },
                {
                    "start": 2056,
                    "end": 2061,
                    "text": "[193]",
                    "ref_id": null
                },
                {
                    "start": 2062,
                    "end": 2067,
                    "text": "[194]",
                    "ref_id": null
                },
                {
                    "start": 2068,
                    "end": 2073,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 2074,
                    "end": 2079,
                    "text": "193t,",
                    "ref_id": null
                },
                {
                    "start": 2080,
                    "end": 2096,
                    "text": "194f and growth,",
                    "ref_id": null
                },
                {
                    "start": 2097,
                    "end": 2101,
                    "text": "186,",
                    "ref_id": null
                },
                {
                    "start": 2102,
                    "end": 2130,
                    "text": "187f heart rate response to,",
                    "ref_id": null
                },
                {
                    "start": 2131,
                    "end": 2136,
                    "text": "[192]",
                    "ref_id": null
                },
                {
                    "start": 2137,
                    "end": 2142,
                    "text": "[193]",
                    "ref_id": null
                },
                {
                    "start": 2143,
                    "end": 2148,
                    "text": "192f,",
                    "ref_id": null
                },
                {
                    "start": 2149,
                    "end": 2153,
                    "text": "195,",
                    "ref_id": null
                },
                {
                    "start": 2154,
                    "end": 2158,
                    "text": "196,",
                    "ref_id": null
                },
                {
                    "start": 2159,
                    "end": 2164,
                    "text": "[191]",
                    "ref_id": null
                },
                {
                    "start": 2165,
                    "end": 2170,
                    "text": "[192]",
                    "ref_id": null
                },
                {
                    "start": 2171,
                    "end": 2176,
                    "text": "191f,",
                    "ref_id": null
                },
                {
                    "start": 2177,
                    "end": 2219,
                    "text": "192f maximal voluntary ventilation during,",
                    "ref_id": null
                },
                {
                    "start": 2220,
                    "end": 2239,
                    "text": "195 oxygen cost of,",
                    "ref_id": null
                },
                {
                    "start": 2240,
                    "end": 2266,
                    "text": "193t oxygen uptake during,",
                    "ref_id": null
                },
                {
                    "start": 2267,
                    "end": 2272,
                    "text": "[190]",
                    "ref_id": null
                },
                {
                    "start": 2273,
                    "end": 2278,
                    "text": "[191]",
                    "ref_id": null
                },
                {
                    "start": 2279,
                    "end": 2284,
                    "text": "[192]",
                    "ref_id": null
                },
                {
                    "start": 2285,
                    "end": 2290,
                    "text": "191f,",
                    "ref_id": null
                },
                {
                    "start": 2291,
                    "end": 2296,
                    "text": "192f,",
                    "ref_id": null
                },
                {
                    "start": 2297,
                    "end": 2301,
                    "text": "193,",
                    "ref_id": null
                },
                {
                    "start": 2302,
                    "end": 2306,
                    "text": "196,",
                    "ref_id": null
                },
                {
                    "start": 2307,
                    "end": 2357,
                    "text": "196f response time of gas exchange adaptations to,",
                    "ref_id": null
                },
                {
                    "start": 2358,
                    "end": 2388,
                    "text": "193t ventilatory responses to,",
                    "ref_id": null
                },
                {
                    "start": 2389,
                    "end": 2394,
                    "text": "[188]",
                    "ref_id": null
                },
                {
                    "start": 2395,
                    "end": 2400,
                    "text": "[189]",
                    "ref_id": null
                },
                {
                    "start": 2401,
                    "end": 2406,
                    "text": "[190]",
                    "ref_id": null
                },
                {
                    "start": 2407,
                    "end": 2412,
                    "text": "189f,",
                    "ref_id": null
                },
                {
                    "start": 2413,
                    "end": 2418,
                    "text": "190f,",
                    "ref_id": null
                },
                {
                    "start": 2419,
                    "end": 2436,
                    "text": "193t VO 2 during,",
                    "ref_id": null
                },
                {
                    "start": 2437,
                    "end": 2457,
                    "text": "58 Exercise testing,",
                    "ref_id": null
                },
                {
                    "start": 2458,
                    "end": 2463,
                    "text": "[186]",
                    "ref_id": null
                },
                {
                    "start": 2464,
                    "end": 2469,
                    "text": "[187]",
                    "ref_id": null
                },
                {
                    "start": 2470,
                    "end": 2475,
                    "text": "[188]",
                    "ref_id": null
                },
                {
                    "start": 2476,
                    "end": 2481,
                    "text": "[189]",
                    "ref_id": null
                },
                {
                    "start": 2482,
                    "end": 2487,
                    "text": "[190]",
                    "ref_id": null
                },
                {
                    "start": 2488,
                    "end": 2493,
                    "text": "[191]",
                    "ref_id": null
                },
                {
                    "start": 2494,
                    "end": 2499,
                    "text": "[192]",
                    "ref_id": null
                },
                {
                    "start": 2500,
                    "end": 2505,
                    "text": "[193]",
                    "ref_id": null
                },
                {
                    "start": 2506,
                    "end": 2511,
                    "text": "[194]",
                    "ref_id": null
                },
                {
                    "start": 2512,
                    "end": 2517,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 2518,
                    "end": 2523,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 2524,
                    "end": 2529,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 2530,
                    "end": 2535,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 2536,
                    "end": 2541,
                    "text": "[199]",
                    "ref_id": null
                },
                {
                    "start": 2542,
                    "end": 2547,
                    "text": "[200]",
                    "ref_id": null
                },
                {
                    "start": 2548,
                    "end": 2553,
                    "text": "[201]",
                    "ref_id": null
                },
                {
                    "start": 2554,
                    "end": 2559,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 2560,
                    "end": 2565,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 2566,
                    "end": 2582,
                    "text": "196f for asthma,",
                    "ref_id": null
                },
                {
                    "start": 2583,
                    "end": 2587,
                    "text": "200,",
                    "ref_id": null
                },
                {
                    "start": 2588,
                    "end": 2617,
                    "text": "817 biologic approach toward,",
                    "ref_id": null
                },
                {
                    "start": 2618,
                    "end": 2623,
                    "text": "[186]",
                    "ref_id": null
                },
                {
                    "start": 2624,
                    "end": 2629,
                    "text": "[187]",
                    "ref_id": null
                },
                {
                    "start": 2630,
                    "end": 2635,
                    "text": "[188]",
                    "ref_id": null
                },
                {
                    "start": 2636,
                    "end": 2640,
                    "text": "200,",
                    "ref_id": null
                },
                {
                    "start": 2641,
                    "end": 2657,
                    "text": "201 methods for,",
                    "ref_id": null
                },
                {
                    "start": 2658,
                    "end": 2680,
                    "text": "197 normal values for,",
                    "ref_id": null
                },
                {
                    "start": 2681,
                    "end": 2697,
                    "text": "198 obesity and,",
                    "ref_id": null
                },
                {
                    "start": 2698,
                    "end": 2728,
                    "text": "196 progressive protocols for,",
                    "ref_id": null
                },
                {
                    "start": 2729,
                    "end": 2734,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 2735,
                    "end": 2740,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 2741,
                    "end": 2756,
                    "text": "196f safety of,",
                    "ref_id": null
                },
                {
                    "start": 2757,
                    "end": 2762,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 2763,
                    "end": 2768,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 2769,
                    "end": 2782,
                    "text": "743 size and,",
                    "ref_id": null
                },
                {
                    "start": 2783,
                    "end": 2788,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 2789,
                    "end": 2794,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 2795,
                    "end": 2800,
                    "text": "[193]",
                    "ref_id": null
                },
                {
                    "start": 2801,
                    "end": 2806,
                    "text": "[194]",
                    "ref_id": null
                },
                {
                    "start": 2807,
                    "end": 2812,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 2813,
                    "end": 2818,
                    "text": "193t,",
                    "ref_id": null
                },
                {
                    "start": 2819,
                    "end": 2824,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 2825,
                    "end": 2830,
                    "text": "[199]",
                    "ref_id": null
                },
                {
                    "start": 2831,
                    "end": 2836,
                    "text": "[200]",
                    "ref_id": null
                },
                {
                    "start": 2837,
                    "end": 2842,
                    "text": "[201]",
                    "ref_id": null
                },
                {
                    "start": 2843,
                    "end": 2848,
                    "text": "199f,",
                    "ref_id": null
                },
                {
                    "start": 2849,
                    "end": 2854,
                    "text": "[815]",
                    "ref_id": null
                },
                {
                    "start": 2855,
                    "end": 2860,
                    "text": "[816]",
                    "ref_id": null
                },
                {
                    "start": 2861,
                    "end": 2882,
                    "text": ", 193-195, 193t, 194f",
                    "ref_id": null
                },
                {
                    "start": 3492,
                    "end": 3497,
                    "text": "(GER)",
                    "ref_id": null
                },
                {
                    "start": 4096,
                    "end": 4102,
                    "text": "(GERD)",
                    "ref_id": null
                },
                {
                    "start": 4107,
                    "end": 4138,
                    "text": ", 192-193, 192f, 195, 196, 196f",
                    "ref_id": null
                },
                {
                    "start": 4173,
                    "end": 4184,
                    "text": "(Continued)",
                    "ref_id": null
                },
                {
                    "start": 4370,
                    "end": 4413,
                    "text": "exercise and, 192-193, 192f, 195, 196, 196f",
                    "ref_id": null
                },
                {
                    "start": 4774,
                    "end": 4789,
                    "text": "induced asthma,",
                    "ref_id": null
                },
                {
                    "start": 4790,
                    "end": 4794,
                    "text": "199,",
                    "ref_id": null
                },
                {
                    "start": 5863,
                    "end": 5919,
                    "text": "34, 35, 35f in saccular period, 2t, 4, 4f-6f, 9, 24, 34-",
                    "ref_id": null
                },
                {
                    "start": 5920,
                    "end": 5925,
                    "text": "[190]",
                    "ref_id": null
                },
                {
                    "start": 5926,
                    "end": 5931,
                    "text": "[191]",
                    "ref_id": null
                },
                {
                    "start": 5932,
                    "end": 5937,
                    "text": "[192]",
                    "ref_id": null
                },
                {
                    "start": 5938,
                    "end": 5943,
                    "text": "191f,",
                    "ref_id": null
                },
                {
                    "start": 5944,
                    "end": 5949,
                    "text": "192f,",
                    "ref_id": null
                },
                {
                    "start": 5950,
                    "end": 5954,
                    "text": "193,",
                    "ref_id": null
                },
                {
                    "start": 5955,
                    "end": 5959,
                    "text": "196,",
                    "ref_id": null
                },
                {
                    "start": 5960,
                    "end": 5973,
                    "text": "196f maximal,",
                    "ref_id": null
                },
                {
                    "start": 5974,
                    "end": 5979,
                    "text": "193t,",
                    "ref_id": null
                },
                {
                    "start": 5980,
                    "end": 5984,
                    "text": "194,",
                    "ref_id": null
                },
                {
                    "start": 5985,
                    "end": 6002,
                    "text": "194f Oxygenation,",
                    "ref_id": null
                },
                {
                    "start": 6003,
                    "end": 6013,
                    "text": "excessive,",
                    "ref_id": null
                },
                {
                    "start": 6032,
                    "end": 6043,
                    "text": "(Continued)",
                    "ref_id": null
                },
                {
                    "start": 7094,
                    "end": 7099,
                    "text": "[190]",
                    "ref_id": null
                },
                {
                    "start": 7100,
                    "end": 7105,
                    "text": "[191]",
                    "ref_id": null
                },
                {
                    "start": 7106,
                    "end": 7111,
                    "text": "[192]",
                    "ref_id": null
                },
                {
                    "start": 7112,
                    "end": 7117,
                    "text": "191f,",
                    "ref_id": null
                },
                {
                    "start": 7118,
                    "end": 7123,
                    "text": "192f,",
                    "ref_id": null
                },
                {
                    "start": 7124,
                    "end": 7128,
                    "text": "193,",
                    "ref_id": null
                },
                {
                    "start": 7129,
                    "end": 7133,
                    "text": "196,",
                    "ref_id": null
                },
                {
                    "start": 7134,
                    "end": 7147,
                    "text": "196f maximal,",
                    "ref_id": null
                },
                {
                    "start": 7148,
                    "end": 7153,
                    "text": "193t,",
                    "ref_id": null
                },
                {
                    "start": 7154,
                    "end": 7158,
                    "text": "194,",
                    "ref_id": null
                },
                {
                    "start": 7159,
                    "end": 7179,
                    "text": "194f VO 2 /HR slope,",
                    "ref_id": null
                },
                {
                    "start": 7180,
                    "end": 7217,
                    "text": "193t VO 2max (maximal oxygen uptake),",
                    "ref_id": null
                },
                {
                    "start": 7218,
                    "end": 7223,
                    "text": "193t,",
                    "ref_id": null
                },
                {
                    "start": 7224,
                    "end": 7228,
                    "text": "194,",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Paired-homeodomain containing (PAX) genes, in Pulmonary Langerhans' cell histiocytosis, (Continued) Rib(s) chondrosarcoma of",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Rib fractures, 1014-1015, 1015f, 1016f Ribavirin for respiratory syncytial virus",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Rifampin for nontuberculous mycobacteria, 526t, 527 for tuberculosis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "519",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "See Familial dysautonomia (FD)",
            "authors": [
                {
                    "first": "Riley-Day",
                    "middle": [],
                    "last": "Syndrome",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Ritonavir and lopinavir (Kaletra), for SARS, 505 RNA polymerase II",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "ROS (reactive oxygen species) in acute lung injury, 230 and bronchopulmonary dysplasia, 348, 349 in sickle cell disease",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Rosai-Dorfman disease, 943 Round pneumonia",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "442",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Respiratory syncytial virus (RSV)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Rsv",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "RTC (rapid thoracoabdominal compression) technique, 129 raised volume, 153-156, 154f-157f squeeze or tidal",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "152--154",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "asthma",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ruttle",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "RV(s) (rhinoviruses), 388-389 and asthma",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "39, 40, 40f, 41, 168, 169f in infants and preschool children",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "RVRTC (raised volume RTC) technique",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "135",
            "issn": "",
            "pages": "154--157",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "RV/TLC (residual volume/total lung capacity) ratio, in restrictive vs. obstructive disorders",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "White blood cell (WBC) count, in pleural fluid",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "375--376",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Whole-body plethysmography",
            "authors": [],
            "year": null,
            "venue": "171f Whole-lung lavage",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "See Pertussis. Williams-Campbell syndrome",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Willi-Prader syndrome, chest wall dysfunction due to",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Wingate test",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Winged helix (HNF) genes, in lung morphogenesis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "7--8",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Wood-burning stoves, and chronic/recurrent bronchitis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "420--421",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Work efficiency, 193t, 194f Work of breathing, 43 Work rates (WRs)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "187",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Wucheria bancrofti, tropical eosinophilia due to",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "See Bronchoalveolar lavage (BAL).",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "See Forced vital capacity (FVC).",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "bacterial pneumonia as, 580b, 581-583 bronchiectasis as, 587 chronic lung disease as, 586-587, 586f, 587f diffuse alveolar damage as, 587 epidemiology of, 580-581, 581t etiology of, 581 fungal infection as, 580b, 583, 584f lymphocytic interstitial pneumonia/pulmonary lymphoid hyperplasia as, 580b, 586-587, 586f, 587f mortality due to, 588 Mycobacterium avium complex as, 582-583 Pneumocystis jiroveci pneumonia as, 583-586, 585f, 585t tuberculosis as, 515, 582 tumors as, 580b, 587 viral infection as, 580b, 583 due to zoster, 551 respiratory infections in, 454t, 455 risk factors for, 579 sarcoidosis and, 932 and upper airway disease, 587-588 Human immunodeficiency virus type 1 (HIV-1). Ibuprofen, for cystic fibrosis, 882 IC (inspiratory capacity), 168, 169f ICAM-1 (intercellular adhesion molecule-1), in airway inflammation, 67 Idiopathic hypereosinophilic syndromes, 697 Idiopathic pulmonary arterial hypertension (IPAH). See Pulmonary arterial hypertension (PAH). Ig(s). See Immunoglobulin(s) (Igs). IKBKAP gene, in familial dysautonomia, 978, 981 IL. See Interleukin (IL) entries. ILCOR (International Liaison Committee on Resuscitation), 317 Illness at presentation, 75 Iloprost, for pulmonary arterial hypertension, 920 Imaging. See Diagnostic imaging. Imipenem, for cystic fibrosis, 880t Immotile cilia syndrome. See Primary ciliary dyskinesia (PCD). Immunotherapy, for asthma, 804, 804f, 828 Impedance, in infants and preschool children, 150-151, 150f, 151f In situ PCR, 400 Inborn errors of metabolism, and SIDS, 1037 Increased inspired mixtures, of oxygen, 53-54 Indirect enzyme immunoassays (indirect EIAs), for pleural effusion due to, 370, 378, 378t in pneumonia, 436 Inflammatory bowel disease, in cystic fibrosis, 894 Inflammatory cells, 65-68, 66f, 68f, 69f in asthma, 812 in generation and amplification of lung injury, Injury(ies). See Trauma. acute lung. See Acute lung injury (ALI).",
            "latex": null,
            "type": "table"
        },
        "TABREF9": {
            "text": "See Cigarette smoke. Smooth muscle, normal anatomy of, 30, 34 Sneezing, as lung defense, 205 Na + ) intake, and asthma, 772 Sodium (Na + ) transport, by alveolar epithelium, 627-628, 627f Soft tissue, radiographic imaging of, 110 Sol layer, 206 Solid-organ transplantation, respiratory infections after, 454-455, 454t, 455t with aspergillosis, 535 Solumedrol, for status asthmaticus, 836-837 Sonic hedge hog (SHH) mutations, 12 Sox-9 mutations, 12 SP-A. See Surfactant protein A (SP-A). SP-B. See Surfactant protein B (SP-B). SP-C. See Surfactant protein C (SP-C). SP-D. See Surfactant protein D (SP-D). Speech sounds, 85 Sphingomyelin, in surfactant, 320 Spin cultures, viral, 394 Spinal cord injury, chest wall dysfunction due to, 736 Spinal muscular atrophies (SMAs) chest wall dysfunction due to, 736 chronic respiratory failure due to, 245, 248-249 Spinal muscular atrophy with respiratory distress type 1 (SMARD1), 737 Spiral computed tomography, 119-120, 120t, 121f Spirograms, volume-time, 175, 176f Spirometer, 174 Spirometry forced expiratory, 171-179 to assess airway reactivity, 176-177, 177f calculation of results of, 175-176, 176f equipment for, 174 flow limitation in, 171-174, 172f-174f historical background of, 171 interpreting results of, 177 procedure for, 174-175, 175f reference standards for, 177-179, 178f in older children, 168, 169f in preschool children, 156-159, 157f-159f Staphylococcus pneumococcus, empyema due to, 378 Starling equation, 624 Starling relationship, in parietal and visceral pleura, 369t, 370t Statins, for pulmonary arterial hypertension, 922 Status asthmaticus, 836-838 Steatosis, in cystic fibrosis, 895, 897 Stenotrophomonas maltophilia, in cystic fibrosis, 873, 874f, 880t Sternal fractures, 1014 Sternocleidomastoid muscles, contraction of, 78 Steroid(s). See Corticosteroids. Steroid-resistant asthma, 282 Stethoscope, 83-84 Still's disease, 959-960 Streptococci, pleural effusions due to, 380t Streptococcus pneumoniae, pneumonia due to, 445, 446f complicated, 445-446 diagnosis of, 443, 444, 445, 446f epidemiology of, 441-442 in immunocompromised host, 459 resistant strains of, 446 treatment for, 449, 449t Streptococcus pyogenes, pneumonia due to, 447 due to upper airway infections, 404 Stromelysins, in acute lung injury, 231t Strongyloides stercoralis, 566, 573 eosinophilic lung disease due to, 695 Strongyloidiasis, 573-574 Structural cells, in airway inflammation, 68, 69f Subacute disease, 75 Subcutaneous emphysema, 381, 383f due to traumatic pneumothorax, 1018, 1019f Suberosis, 692t Subglottic cyst, 107f Subglottic foreign bodies, 611 Subglottic hemangioma, 293, 293f Subglottic stenosis, 293-294 Submucosa, normal anatomy of, 30 Substance P, in airway inflammation, 71 Sudden infant death syndrome (SIDS), 1034-1042 acute life-threatening event and, 1027 apoptosis and, 1036 arousal from sleep and, 1040, 1048 defined, 1034 epidemiology of, 1028f, 1028t fatty acid oxidation deficiencies and, 1037 genetic diseases of metabolism and, 1037 vs. infanticide, 1038 neural receptors and, 1036-1037 pathology of, 1035-1038 respiratory control system in, 62-63 risk factors for, 1028t, 1034-1035, 1035f scene investigations of, 1038, 1039-1040, 1039f sleep practices and, 1035, 1035f, 1038-1042, 1041f triple-risk model for, 1034-1035, 1035f Sulfasalazine, lung injury due to, 1001t, 1005 51-53, 52f, 53t in oxygen therapy, 53-55, 54b and tissue respiration, 58-59 Systemic lupus erythematosus (SLE), 949-955 case studies of, 952-954, 952t, 953f, 954f, 954t clinical manifestations of, 949-952, 950t, 951t diagnostic and therapeutic considerations in, 949, 954-955 drug-induced, 952 Systemic manifestations, of cystic fibrosis, 888b Systemic oxygen transport equation, 53 Systemic respiration, mitochondrial and, 189f Systemic sclerosis, 950t, 955-958, 957f, 957t Systolic blood pressure, normal values for, 232t Taurine therapy, for cystic fibrosis-associated liver disease, 897 TB. See Tuberculosis (TB). Terminal bronchioles, normal anatomy of, 29, 30f Terminal respiratory unit, normal anatomy and cell function of, 30-32, 30f, 31f, 32t Tetramethyl rhodamine isothiocyanate, for viral immunoassays, 393 TGF-\u03b2 (transforming growth factor-\u03b2), in airway inflammation, 70 TGI (tracheal gas insufflation), for ARDS, 642 TGV (thoracic gas volume), plethysmographic assessment of, 170-171, 171f Th1 cells. See T helper 1 (Th1) cells. Th2 cells. See T helper 2 (Th2) cells. THAM (tromethamine), for pulmonary hypertension of the newborn, 331 Theophylline for apnea, 319 of prematurity, 1034, 1055 for asthma, 823t, 824, 830 Thermal stress, and SIDS, 1039, 1040, 1041 Thermal volume, of lung, in pulmonary edema, 629 Thiabendazole, for strongyloidiasis, 574, 695 Thoracentesis, for pleural effusions, 373, 379-380 Thoracic acoustics, 81-83, 81f, 82f Thoracic aorta, traumatic rupture of, 1022 Thoracic compliance, 39, 40f Thoracic depth, 79, 80f Thoracic gas volume (TGV), plethysmographic assessment of, 170-171, 171f Thoracic index, 79-80 Thoracic malformation, congenital, 281t, 282 Thymus-and activation-regulated chemokine (TARC), in airway inflammation, 70 Thyroarytenoid muscles, in respiration, 46 Thyroid disorders, 728 Thyroid hormones, for prevention of respiratory distress syndrome, 324 Thyroid transcription factor-1 (TTF-1) in lung morphogenesis, 7, 7f, 9 mutations in, 12 Thyroid-releasing hormone (TRH), for prevention of respiratory distress syndrome, 324 Ticarcillin for bacterial pleurisy and empyema, 380t for cystic fibrosis, 880t Ticarcillin/clavulanate, for cystic fibrosis, 880t Tidal breathing parameters, in infants and preschool children, 135-137, 135f, 136f Tidal breathing ratio, in infants and preschool children, 136, 137 Tidal flow-volume loops, in infants and preschool children, 135, 135f, 136f Tidal RTC technique, 152-153, 152f-154f Tidal volume (VT), 39, 40, 40f, 47-48, 168, 169f normal values for, 232t Time-resolved fluoroimmunoassay, for respiratory viruses, 395 Tinkling crackle, 82 Tissue(s), oxygen delivery to, 53 Tissue inhibitors of metalloproteinases (TIMPs), in hypersensitivity pneumonitis, 689 Tissue respiration, 58-59 Tissue viscous resistance, 42 TLC. See Total lung capacity (TLC). TMP-SMX. See Trimethoprim/sulfamethoxazole (TMP-SMX, co-trimoxazole). TNF. See Tumor necrosis factor (TNF) entries. Tobacco smoke. See Cigarette smoke. Tobramycin for bacterial pleurisy and empyema, 380t for cystic fibrosis, 880, 880t Toll-like receptors (TLRs), as lung defenses, 207, 209-210, 209t Toluene diisocyanate (TDI) hypersensitivity pneumonitis, 692t Tonsil(s), aerodynamic filtering by, 205 Tonsillectomy, for obstructive sleep apnea, 1063 \"Toothpaste\" shadows, in allergic bronchopulmonary aspergillosis, 699b, 700 Total lung capacity (TLC), 39, 40, 40f, 41, 168, 169f in children, 168 in mixed restrictive and obstructive processes, 179 in scoliosis, 743 Total pulmonary resistance, measurement of, 42 Toxic lung injury, pulmonary edema in, 634 Toxocara canis, eosinophilic lung disease due to, Tram line\" shadows, in allergic bronchopulmonary aspergillosis, 699-700, 699b trans fatty acids, and asthma, 772 Transacting factors, in lung morphogenesis, 7 trans-activating domains, in lung morphogenesis, Transthoracic aspiration (TTA) for anaerobic lung infection and lung abscess, 480 in immunocompromised patient, 461 Transtracheal aspirates, 390 Transudates, pleural effusion of, 374-375, 377, 377t \"Trapped gas,\" 41 Trauma, 1014-1025 atelectasis due to, 1020-1021 cardiac, 1021-1022, 1021f-1023f due to drowning, 662-663 to esophagus, 1022-1023 hemothorax due to, 1018-1019, 1020f pleural effusion due to, 378 pneumothorax due to, 1017-1018, 1018f, 1019f pulmonary compression injury due to, 1019-1020, 1020f rib fractures due to, 1014-1015, 1015f, 1016f rupture of diaphragm due to, 1023-1025, 1024f-1025f rupture of thoracic aorta due to, 1022 sternal fractures due to, 1014 thoracoabdominal injuries due to, 1014, 1015f, 1023-1025, 1024f-1025f tracheobronchial, 1019 tracheostomy in chest wall injury due to, 1015-1017, 1017f Traumatic asphyxia, 1019-1020, 1020f Traumatic pneumothorax, 1017-1018, 1018f, 1019f Traumatic scoliosis, 742b Treadmill test, 197 for asthma, 817 Treprostinil sodium, for pulmonary arterial hypertension, 920 TRH (thyroid-releasing hormone), for prevention of respiratory distress syndrome, 324 Triamcinolone, for asthma, 820, 825, 829t Trichosporon asahii, 540 Trichosporon beigelii, 540 in immunocompromised host, 459 Trichosporon spp, 540 Trigeminal nerve, in respiratory control, 60 Trimethoprim/sulfamethoxazole (TMP-SMX, co-trimoxazole) for chronic granulomatous disease, 988 for cystic fibrosis, 880t for nontuberculous mycobacteria, 526t for Pneumocystis jiroveci pneumonia, 457 with HIV, 585, 586 Trisomy, pulmonary hypoplasia in, 334f Tromethamine (THAM), for pulmonary hypertension of the newborn, 331 Tropical eosinophilia, 694-695 Tryptase, released by mast cells, 213t TTA (transthoracic aspiration) for anaerobic lung infection and lung abscess, 480 in immunocompromised patient, 461 TTF-1 (thyroid transcription factor-1) in lung morphogenesis, 7, 7f, 9 mutations in, 12 TTN (transient tachypnea of the newborn), 325-326, 326f Tube thoracostomy, for intrapleural air, 386 Tube wave speed, 172 Tuberculin skin test, 516-518, 517b Tuberculosis (TB), 507-522",
            "latex": null,
            "type": "table"
        },
        "TABREF10": {
            "text": "Tuberculosis purified protein derivative (Tubersol, Aplisol), 516 Tuberculous effusions, 378, 379 Tuberculous meningitis, 511, 515-516, 516f, 521 Tuberous sclerosis, 311 pulmonary hemorrhage with, 682-683 Tubersol (tuberculosis purified protein derivative), 516 Tubular myelin, in surfactant life cycle, 18, 18f Tubulin, in cilia, 902 Tucson Children's Respiratory Study, 162, Tumor necrosis factor-\u03b2 (TNF-\u03b2), in airway inflammation, 69-70 Turkey handler's disease, 692t UAC (umbilical arterial catheter), for respiratory distress syndrome, 323 UAO. See Upper airway obstruction (UAO). UDCA (ursodeoxycholic acid), for cystic fibrosis-associated liver disease, 897 UES (upper esophageal sphincter) pressure, in gastroesophageal reflux, 598 UGI (upper gastrointestinal) series, for gastroesophageal reflux and/or aspiration, 600, 601t UIP (usual interstitial pneumonia), 666-667, 671 Ultrasonic flowmeters, 136 Ultrasonic nebulizers, 273-274, 274f Ultrasonography, 127-128, 127f, 128f of congenital lung disease, 312 of pleural effusion, 372, 375f, 705, 707f prenatal, of tumors, 710 Umbilical arterial catheter (UAC), for respiratory distress syndrome, 323 Upper airway(s) congenital abnormalities of, 288-295, 289f, 289t of larynx, 289t, 290-294, 291f, 293f of trachea, 289t, 294-295, 294f developmental changes in, and pulmonary function tests, 130 sensory receptors in, 60 during sleep, 1049-1051 Upper airway disease, with HIV, 587-588 Upper airway dysfunction, 1051 Upper airway infection, bronchiectasis due to, 465 Upper airway obstruction (UAO), 62 anatomic and physiologic basis for, 404, 405f extrathoracic vs. noninfective causes of, 406-407, 407b Upper airway resistance, in sleep, 248 Upper esophageal sphincter (UES) pressure, in gastroesophageal reflux, 598 Upper gastrointestinal (UGI) series, for gastroesophageal reflux and/or aspiration, 600, 601t Upper motor neuron disease, chest wall dysfunction due to, 736b Upper respiratory tract atresia, 288, 288f Upper respiratory tract infection, bronchiectasis due to, 465 Ureaplasma urealyticum and bronchopulmonary dysplasia, 350 pneumonia due to, 441 Uremia, with pulmonary edema, 633 Ursodeoxycholic acid (UDCA), for cystic fibrosis-associated liver disease, 897 Usual interstitial pneumonia (UIP), 666-667, 671 Uveoparotid fever, in sarcoidosis, 931 Uvulopharyngopalatoplasty, for obstructive sleep apnea, 1063 Varicella-zoster immune globulin (VZIG), 553 Varicella-zoster virus (VZV), 550 Vas deferens, congenital bilateral absence of, in cystic fibrosis, 855, 888 Vascular cell adhesion molecule-1 (VCAM-1), in airway inflammation, 67 Vascular endothelial growth factor (VEGF) in airway inflammation, 70 and bronchopulmonary dysplasia, 351 Vascular endothelial growth factor A (VEGF-A), in lung morphogenesis, 10 Vascular forces, in pulmonary edema, 624 Vascular lymphatic abnormalities, of mediastinum, 727, 727f Vascular obstruction, in sickle cell disease, VC (vital capacity), 39, 40, 40f, 41, 168, 169f VCAM-1 (vascular cell adhesion molecule-1), in airway inflammation, 67 VCD (vocal cord dysfunction), 814-815, 815f VCO 2 (carbon dioxide uptake), 58-59 during exercise, 194-195 VCP (vocal cord paralysis), congenital, 292 VD. See Dead space (VD). VD/VT ratio, 225 Vegetables, and asthma, 771-772 VEGF (vascular endothelial growth factor) in airway inflammation, 70 and bronchopulmonary dysplasia, 351 VEGF-A (vascular endothelial growth factor A), in lung morphogenesis, 10 Veno-occlusive disease, pulmonary hemorrhage See Mechanical ventilation. in scoliosis, 743 Ventilation inhomogeneity, in infants and preschool children, 140-142, 142f, 143f Ventilation/perfusion isotope study, 128f Ventilation-perfusion mismatch, 51 hypoxic respiratory failure due to, 245 Ventilation-perfusion scanning, of congenital lung disease, 311-312 Ventilator-associated pneumonia, 327-328 Ventilator-induced lung injury (VILI), 236 Ventilatory control in obstructive sleep apnea, 1050-1051 respiratory muscle weakness and, 247 Ventilatory drive, respiratory muscle weakness and, 247 Ventilatory pump failure, 243-244 clinical presentation of, 245-247, 246t oxygen-carbon dioxide diagram in, 243, 244f Ventilatory response(s) to exercise, 188-190, 189f, 190f, 193t hypercapnic, 251 hypoxic, 251 and SIDS, 1040 during sleep, 1049 Ventilatory support. See Mechanical ventilation. Ventilatory threshold (VAT), 193t Ventral plate, in lung morphogenesis, 8 Ventstream nebulizer, 274, 275 Venturi effect, 404 Very late antigen-4 (VLA-4), in airway inflammation, 67 Very long chain acyl-CoA dehydrogenase (VLCAD), and SIDS, 1037 VHCs (valved holding chambers), for metereddose inhalers, 268, 272, 278t Vibrating-membrane nebulizers, 274 VILI (ventilator-induced lung injury), 236 Vinblastine, lung injury due to, 1004 Vinca alkaloids, lung injury due to, 1004 Vindesine, lung injury due to, 1004 Viral antigen detection, 393-395 due to varicella-zoster virus, 551-553 virus receptors on host cells in, 435-436 Virions, 393, 393t Virus cultures, 388, 390-391, 391f, 391t Visceral larva migrans (VLM), 566-567 Visceral pleura, 368, 369t Vital capacity (VC), 39, 40, 40f, 41, 168, 169f Vitamin(s), for cystic fibrosis, 897, 897t, 899, 899t Vitamin A, for cystic fibrosis, 897t, 899, 899t Vitamin A deficiency, and bronchopulmonary dysplasia, 350 Vitamin D, for cystic fibrosis, 897t, 899, 899t Vitamin E, for cystic fibrosis, 897t, 899, 899t Vitamin E deficiency and bronchopulmonary dysplasia, 350 in cystic fibrosis, 863 Vitamin K, for cystic fibrosis, 897t, 899, 899t VLA-4 (very late antigen-4), in airway inflammation, 67 VLCAD (very long chain acyl-CoA dehydrogenase), and SIDS, 1037 VLM (visceral larva migrans), 566-567 VM-26, lung injury due to, 1004 VO 2 (oxygen uptake), 58-59 during exercise,",
            "latex": null,
            "type": "table"
        },
        "TABREF11": {
            "text": "occlusive crisis), in sickle cell disease, 992 Volatile hydrocarbons, \"sniffing\" of, 655 Volatile liquids, aspiration of, 603-604 Volatile organic compounds, and asthma, 776 Volitional tests, of respiratory muscle strength, 251-252 Volume loss, on chest radiograph, 114, 115f Volume rendering, of computed tomography, 121f Volume-controlled ventilation, for acute respiratory failure, 235-236, 236t Volume-time spirograms, 175, 176f Volutrauma, and bronchopulmonary dysplasia, 348-349 von Recklinghausen's disease, 728 von Willebrand factor (vWF) production of, 33 in sickle cell disease, 993 von Willebrand factor antigen (vWF-Ag), in ARDS, 647 Voriconazole, for aspergillosis, 537 VP-16, lung injury due to, 1003 VT (tidal volume), 39, 40, 40f, 47-48, 168, 169f normal values for, 232t vWF (von Willebrand factor) production of, 33 in sickle cell disease, 993 vWF-Ag (von Willebrand factor antigen), in ARDS, 647 VZIG (varicella-zoster immune globulin), 553 VZV (varicella-zoster virus), 550 Warfarin, for pulmonary arterial hypertension, 918 Warthin-Finkeldey cells, 556 Water lily sign, in hydatid disease, 570 Water vapor pressure, 38 WBC (white blood cell) count, in pleural fluid, 375-376 Weather, and asthma, 777-778, 815 Wegener's granulomatosis (WG), 964-967 Western blot, for respiratory viruses, 397 West's zones of perfusion, 45, 45f Wet lungs, 325-326, 326f, 1020-1021 WG. See Wegener's granulomatosis (WG).",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "R R (respiratory exchange ratio), 48-49 during exercise, 194-195 rac2, in ",
            "cite_spans": [
                {
                    "start": 34,
                    "end": 73,
                    "text": "48-49 during exercise, 194-195 rac2, in",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}